Search Results - "Rangaraju, M."

Samarendra Nath Talukdar (1928–2013) by Desai, R. N., Rangaraju, M. K.

Get full text

Telithromycin 800 mg once daily for seven to ten days is an effective and well-tolerated treatment for community-acquired pneumonia by Carbon, C., Moola, S., Velancsics, I., Leroy, B., Rangaraju, M., Decosta, P.

“…This open, multinational study examined the efficacy and tolerability of telithromycin (HMR 3647), the first ketolide antibacterial agent, at an oral dose of…”
Get full text

Telithromycin is as effective as amoxicillin/clavulanate in acute exacerbations of chronic bronchitis by AUBIER, M, ALDONS, P.M, LEAK, A, MCKEITH, D.D, LEROY, B, RANGARAJU, M, BIENFAIT-BEUZON, C

“…This randomized, double-blind study evaluated the efficacy and safety of a short, 5-day course of telithromycin, a new ketolide antibacterial, compared with a…”
Get full text

Efficacy and tolerability of once-daily Telithromycin compared with high-dose amoxicillin for treatment of community-acquired pneumonia by HAGBERG, L, TORRES, A, VAN RENSBURG, D, LEROY, B, RANGARAJU, M, RUUTH, E

“…This randomized, double-blind study compared the efficacy and tolerability of the new ketolide antimicrobial telithromycin with that of high-dose amoxicillin…”
Get full text

Five-day telithromycin once daily is as effective as 10-day clarithromycin twice daily for the treatment of acute exacerbations of chronic bronchitis and is associated with reduced health-care resource utilization by Fogarty, Charles, de Wet, Ronelle, Mandell, Lionel, Chang, Joanne, Rangaraju, Manickam, Nusrat, Roomi

“…To demonstrate equivalence in the clinical efficacy of telithromycin vs clarithromycin treatment of outpatients with acute exacerbations of chronic bronchitis…”
Get more information

Clinical efficacy and tolerability of direct-acting antivirals in elderly patients with chronic hepatitis C by Sherigar, Jagannath M, Gayam, Vijay, Khan, Arifa, Mukhtar, Osama, Arefiev, Yavgeniy, Khalid, Mazin, Siddiqui, Imran, Rangaraju, Ayyappa M, Budhathoki, Nibash, Mansour, Mohammed, Guss, Debra, Mohanty, Smruti R

“…BACKGROUNDThere is a lack of evidence-based data on aged patients with newer direct-acting antivirals (DAAs) and with shorter duration of treatment regimens…”
Get full text

Clinical and bacteriological efficacy of 5-day telithromycin in acute maxillary sinusitis: a pooled analysis by Roos, K., Tellier, G., Baz, M., Leroy, B., Rangaraju, M.

“…Objectives. To compare the efficacy and tolerability of a 5-day course of telithromycin (800 mg once daily) with a 10-day course of telithromycin or standard…”
Get full text

Efficacy and tolerability of once-daily therapy with telithromycin for 5 or 10 days for the treatment of acute maxillary sinusitis by Roos, K, Brunswig-Pitschner, C, Kostrica, R, Pietola, M, Leroy, B, Rangaraju, M, Boutalbi, Y

“…The efficacy and tolerability of oral telithromycin 800 mg once daily for 5 vs. 10 days were assessed in patients with acute maxillary sinusitis (AMS). Adults…”
Get more information

Bacteriological efficacy of 5-day therapy with telithromycin in acute maxillary sinusitis by Buchanan, P., Roos, K., Tellier, G., Rangaraju, M., Leroy, B.

“…Increasing resistance among the key pathogens responsible for community-acquired respiratory tract infections, namely Streptococcus pneumoniae, Haemophilus…”
Get full text

P793 Pharmacokinetic/pharmacodynamic modelling of the plasma bactericidal activity of NXL103 against Streptococcus pneumoniae and Staphylococcus aureus in phase I studies by Merdjan, H, Lowther, J, Girard, A.-M, Delachaume, C, Rangaraju, M

Get full text

Clinical and bacteriologic efficacy of telithromycin in patients with bacteremic community-acquired pneumonia by Carbon, C., van Rensburg, D., Hagberg, L., Fogarty, C., Tellier, G., Rangaraju, M., Nusrat, R.

“…This retrospective analysis was performed to determine the clinical and bacteriologic efficacy of the ketolide antibacterial telithromycin in patients with…”
Get full text

Telithromycin for the treatment of acute exacerbations of chronic bronchitis by Fogarty, C, Zervos, M, Tellier, G, Aubier, M, Rangaraju, M, Nusrat, R

“…Pooled data from three randomized, double-blind, multi- centre studies evaluated the efficacy and tolerability of telithromycin 800 mg once daily for 5 days…”
Get more information

Evaluation of 5-day therapy with telithromycin, a novel ketolide antibacterial, for the treatment of tonsillopharyngitis by Norrby, S.R., Quinn, J., Rangaraju, M., Leroy, B.

“…A pooled analysis of two double-blind, multicentre, Phase III studies compared oral telithromycin 800 mg once-daily for 5 days with penicillin V 500 mg…”
Get full text

Efficacy of platelet rich fibrin in the treatment of human intrabony defects with or without bone graft: A randomized controlled trial by Chandradas, Nikhil, Ravindra, Shivamurthy, Rangaraju, Vivekananda, Jain, Sheetal, Dasappa, Shivaprasad

“…Aim: To evaluate the efficacy of platelet rich fibrin (PRF) with or without bone graft [demineralized bone matrix (DBM) graft] in the treatment of intrabony…”
Get full text

Low power Viterbi decoder design based on reversible logic gates by Naveen, K. B., Puneeth, G. S., Sree Rangaraju, M. N.

“…In recent trends of VLSI technology the reversible logic has became the major area of research in optimization of area, power and speed constraints. The…”
Get full text

Efficacy of telithromycin in community-acquired pneumonia caused by pneumococci with reduced susceptibility to penicillin and/or erythromycin by van Rensburg, D J, Fogarty, C, Kohno, S, Dunbar, L, Rangaraju, M, Nusrat, R

“…The efficacy of oral telithromycin was assessed in patients with community-acquired pneumonia (CAP) caused by Streptococcus pneumoniae with reduced…”
Get more information

Pharmacodynamics of an 800-mg dose of telithromycin in patients with community-acquired pneumonia caused by extracellular pathogens by Lodise, Thomas P., Preston, Sandra, Bhargava, Vijay, Bryskier, Andre, Nusrat, Roomi, Chapel, Sonny, Rangaraju, Manichan, Drusano, George L.

“…The pharmacodynamics of telithromycin, a new ketolide antibacterial, was examined in 115 patients with community-acquired pneumonia (CAP). Patients received…”
Get full text

Efficacy of Short-course Therapy with the Ketolide Telithromycin Compared with 10 Days of Penicillin V for the Treatment of Pharyngitis/Tonsillitis by NORRBY, S. Ragnar, RABIE, Willem J, BACART, Patrick, MUELLER, Otmar, LEROY, Bruno, RANGARAJU, Manickam, BUTTICAZ-IROUDAYASSAMY, Emmanuelle

“…This randomized, double-blind study compared the efficacy and safety of a 5-d course of the new ketolide antimicrobial, telithromycin, with those of a standard…”
Get full text

Activity of telithromycin against key pathogens associated with community-acquired respiratory tract infections by Low, Donald E, Felmingham, David, Brown, Steve D, Rangaraju, Manickam, Nusrat, Roomi

“…Objectives. To investigate the correlation between in vitro susceptibility of isolates and clinical outcomes with telithromycin in respiratory tract…”
Get full text

Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients by CHEHIMI, J, STARR, S. E, WOLF, S. F, TRINCHIERI, G, FRANK, I, RANGARAJU, M, JACKSON, S. J, LLANES, C, KOBAYASHI, M, PERUSSIA, B, YOUNG, D, NICKBARG, E

“…Natural killer cell stimulatory factor (NKSF), or interleukin 12 (IL-12), is a heterodimeric lymphokine produced by B cells that has multiple effects on T and…”
Get full text